🔥The 9th Round of Easy Loan, Earn $40 Reward is in progress❗️ ⏰ Promotion Period: January 15th - Feburary 15th, 2025 👉 Register now and check more details at gate.io/campaigns/358

Thanks again to everyone who attended our Twilight briefing with Neuren and Dimerix, and to FB Rice for sponsoring the event! If you weren't able to join us a recording of the event is now available our Youtube channel: youtube.com/watch?v=rxGgYi…

The next edition of our Twilight series features Carina Biotech and AdAlta Limited (ASX:1AD). Is CAR-T the next big thing in solid cancer treatment? How can specially engineered i-bodies improve drug targeting problems? Join us on 25 May to find out: bit.ly/3IetB4V

Thank you to everyone who attend our Twilight briefing with AdAlta Limited & Carina Biotech yesterday on a rainy Melbourne evening, to FB Rice for sponsoring & Niv Dagan from @PeakAsset for hosting! The recording is now up on our Youtube channel: bit.ly/3MyDITf

Our next Twilight features global pharmaceutical company & pioneers in photomedicine CLINUVEL (ASX:CUV). The company has launched its first photocosmetic product with further product lines planned in DNA skin repair & risk-free tanning. Register: bit.ly/3NhzBvo

Join our Twilight this Thurs 24 Aug with Prescient Therapeutics PTX, Novel Cancer Therapies (ASX:PTX) & FOS Capital (ASX:FOS). PTX is a clinical stage oncology company with targeted & cell therapy platforms. FOS is a profitable growth company providing innovative lighting solutions. Register: bit.ly/3sjfFkV

Twilight alert! Paradigm Biopharma (PAR) repurposes underutilised drugs & molecules for unmet needs, with Ph3 trials for #OA. Immuron Ltd. (IMC) develops oral targeted antibodies to treat gut mediated diseases; record quarterly #Travelan sales of $1.5M. Register: bit.ly/45sU2fZ

Another great Twilight session, thank you Paradigm Biopharma and Immuron Ltd. for presenting, and to everyone who attended! If you missed out you can watch the recording here: youtu.be/F8VdculTBZM As always thanks to FB Rice for sponsoring the event!

Great to see some of our clients presenting the biotech story at the #AusMicrocap Investment Conference yesterday Biotron (ASX:BIT) Dimerix Pharmaxis Thank you for inviting us Australian Microcap!

We’re kickstarting our Twilight series this Wednesdau with global lysyl oxidase enzymes leader Syntara Limited & CAR-T immunotherapy company Carina Biotech. Join us for presentations followed by drinks & canapes, kindly sponsored by FB Rice! Register: forms.gle/hh1GC9Ti8vbWvv…

After a brief hiatus we’re looking forward to our Twilight featuring Neuren ($NEU) and Dimerix ($DXB), two biotechs to watch. Join us next Thursday 13 June for presentations followed by drinks and canapes sponsored by FB Rice: forms.gle/UpFx6UHxuqmJ2h…

With around a 50% failure rate in type 2 diabetes treatments within ~16 months in the US, new treatment options are critical. Well done Myopharm Limited for the feature!

Thanks to everyone who attended our Twilight with Cleodx & BirdDog. If you missed out you can watch the recording here: youtu.be/ApN441NAh-Y The session was streamed using 2 BirdDog cameras & managed on one platform. Tune in to see the difference!

A big thank you to all involved in our #BiotechShowcase yesterday, held together with @PeakAsset and sponsored by FB Rice. We hope everyone walked away with new insights, connections, and a stock pick or two!

📢 Join the #TwilightInvestorBriefing for unique insights into high-growth biotech opportunities. Hear from Race Oncology & islandpharmaceuticals on breakthroughs poised to make an impact. Secure your spot ➡️ bit.ly/TwilightNov2024  #InvestorEvent #BiotechInvesting

Watch the full replay of our latest #TwilightInvestorBriefing powered by FB Rice, featuring Race Oncology & islandpharmaceuticals, the future of healthcare investment. 🚀Gain insights on their revolutionary solution for cancer & dengue: bit.ly/3Zj8GVS #Biotech

Join us at the upcoming #TwilightInvestorBriefing—supported by FB Rice—featuring Prescient Therapeutics PTX, Novel Cancer Therapies (ASX: PTX) & Amplia Therapeutics (ASX: ATX), advancing cancer therapies with FDA backing & orphan drug designations. 🔗 RSVP now: bit.ly/reg-twilight-p… #biotech #oncology #PTX #ATX